Mesa Laboratories (MLAB) EPS (Weighted Average and Diluted) (2010 - 2025)

Mesa Laboratories has disclosed EPS (Weighted Average and Diluted) across 16 years of filings, most recently posting $0.65 for Q4 2025.

• EPS (Weighted Average and Diluted) for Q4 2025 came in at $0.65, up 309.68% year-over-year; the trailing twelve-month figure through Dec 2025 was $0.65 (up 101.4% YoY), and the FY2025 annual result was -$0.36, up 99.24% from the prior year.
• EPS (Weighted Average and Diluted) came in at $0.65 for Q4 2025 at Mesa Laboratories, up from $0.45 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.85 in Q2 2025 to a low of -$47.26 in Q1 2024.
• The 5-year median for EPS (Weighted Average and Diluted) is $0.18 (2023), against an average of -$2.22.
• Peak annual rise in EPS (Weighted Average and Diluted) reached 720.0% in 2024, while the deepest fall reached 43063.64% in 2024.
• Mesa Laboratories' EPS (Weighted Average and Diluted) stood at -$0.39 in 2021, then surged by 120.51% to $0.08 in 2022, then surged by 387.5% to $0.39 in 2023, then slumped by 179.49% to -$0.31 in 2024, then jumped by 309.68% to $0.65 in 2025.
• The last three EPS (Weighted Average and Diluted) figures came in at $0.65 (Q4 2025), $0.45 (Q3 2025), and $0.85 (Q2 2025), per Business Quant data.